Public Health Measures and Prevention of Alcohol-Associated Liver Disease

Ayares, Gustavo; Idalsoaga, Francisco; Arnold, Jorge; Fuentes-Lopez, Eduardo; Arab, Juan P.; Diaz, Luis A.

Abstract

Hazardous alcohol consumption causes approximately 4% of deaths globally, constituting one of the leading risk factors for the burden of the disease worldwide. Alcohol has several health consequences, such as alcohol -associated liver disease, hepatocellular carcinoma, nonliver neoplasms, physical injury, cardiac disease, and psy-chiatric disorders. Alcohol misuse significantly affects workforce productivity, with elevated direct and indirect economic costs. Due to the high impact of alcohol consumption on the population, public health has led to the development of a range of strategies to reduce its harmful effects. Regulatory public health policies (PHP) for alcohol can exist at the global, regional, international, national, or subnational levels. Effective strategies incor-porate a multilevel, multicomponent approach, targeting multiple determinants of drinking and alcohol-related harms. The World Health Organization categorizes the PHP into eight categories: national plan to fight the harmful consequences of alcohol, national license and production and selling control, taxes control and pricing policies, limiting drinking age, restrictions on alcohol access, driving-related alcohol policies, control over adver-tising and promotion, and government monitoring systems. These policies are supported by evidence from different populations, demonstrating that determinants of alcohol use depend on several factors such as socio-economic level, age, sex, ethnicity, production, availability, marketing, and others. Although most policies have a significant individual effect, a higher number of PHP are associated with a lower burden of disease due to alcohol. The excessive consequences of alcohol constitute a call for action, and clinicians should advocate for developing and implementing a new PHP on alcohol consumption. (J CLIN EXP HEPATOL 2022;12:1480-1491)

Más información

Título según WOS: ID WOS:000886552800011 Not found in local WOS DB
Título de la Revista: JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY
Volumen: 12
Número: 6
Editorial: ELSEVIER - DIVISION REED ELSEVIER INDIA PVT LTD
Fecha de publicación: 2022
Página de inicio: 1480
Página final: 1491
DOI:

10.1016/j.jceh.2022.05.005

Notas: ISI